Revolution Medicines gains after report co in talks to be acquired by Merck

Erasca

08/01/2026 22:12

** Shares of Revolution Medicines RVMD.O up 16% at $125 in after-market trading

** Merck's MRK.N shares marginally down 0.6% at $110.30

** Peer cancer therapy developer Erasca ERAS.O up 10.2% at $6.40

** Merck is in talks to buy cancer drug developer Revolution Medicines, the Financial Times reported on Thursday, citing people familiar with the matter

** MRK and RVMD did not immediately respond to Reuters' requests for comment

** As of Thursday's close, MRK up 2.2%, RVMD up 4.6% and ERAS up 56.2% YTD

 (Reporting by Megavarshini G. Somasundaram in Bengaluru)

 ((Megavarshini.SomasundaramGnanasundari@thomsonreuters.com))